Navigator

      Support By : Li-lab

Drug-Pathway
DRUGs and PATHWAYs
PATHWAY_NAME REACTOME_ID KEGG_ID DRUG_NAME PUBCHEM_CID Datasource
Systemic lupus erythematosus R-HSA-977105 map05322 sulfadoxine 5328 drug-path
Pancreatic cancer R-HSA-9700206 map05212 sulfadoxine 5328 drug-path
Prostate cancer R-HSA-2990872 map05215 sulfadoxine 5328 drug-path
ErbB signaling pathway R-HSA-168638 map04012 sulfadoxine 5328 drug-path
Non-small cell lung cancer R-HSA-5619066 map05223 sulfadoxine 5328 drug-path
Jak-STAT signaling pathway R-HSA-168638 map04630 sulfadoxine 5328 drug-path
mTOR signaling pathway R-HSA-165662 map04150 sulfadoxine 5328 drug-path
Alzheimer's disease R-HSA-1643685 0 sulfadoxine 5328 drug-path
Neuroactive ligand-receptor interaction R-HSA-5632681 map04080 sulfadoxine 5328 drug-path
Calcium signaling pathway R-HSA-381753 map04020 sulfadoxine 5328 drug-path
Olfactory transduction R-HSA-9751605 map04740 pyrimethamine 10921 drug-path
Non-homologous end-joining R-HSA-5693571 map03450 pyrimethamine 10921 drug-path
RNA polymerase R-HSA-73864 map03020 pyrimethamine 10921 drug-path
Olfactory transduction R-HSA-9751605 map04740 ticlopidine 5472 drug-path
Systemic lupus erythematosus R-HSA-977105 map05322 ticlopidine 5472 drug-path
Non-homologous end-joining R-HSA-5693571 map03450 ticlopidine 5472 drug-path
Olfactory transduction R-HSA-9751605 map04740 cinchocaine 3025 drug-path
Phosphatidylinositol signaling system R-HSA-1280215 map04070 cinchocaine 3025 drug-path
Axon guidance R-HSA-422475 map04360 cinchocaine 3025 drug-path
VEGF signaling pathway R-HSA-194138 map04370 cinchocaine 3025 drug-path